Physician profile
Jeffrey C Gadsden
NPI 1376605063
$821,270.58
in general payments reported to CMS, 2019-2025
12 companies · $157K in 2025
The $157K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85K · 2020: $86K · 2021: $166K · 2022: $100K · 2023: $58K · 2024: $169K · 2025: $157K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $247K · Honoraria: $54K · Travel and Lodging: $45K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Food and Beverage: $5,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $246,970.00 |
| Honoraria | $53,525.00 |
| Travel and Lodging | $44,652.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,000.00 |
| Food and Beverage | $5,517.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $768,858.80 | 2019-2025 | Exparel, Iovera, Zilretta |
| Ge Healthcare | $40,173.66 | 2025 | |
| Pajunk Medical Systems, Lp | $6,904.93 | 2021-2023 | E-Cath Plus Acc. Tsui |
| Medical Device Business Services, INC. | $4,120.00 | 2020 | |
| Pacira Therapeutics, INC. | $550.00 | 2019 | |
| Avanos Medical | $360.85 | 2019-2025 | Pnb and Accessories |
| Mindray Ds USA, INC. | $148.50 | 2025 | Te X, Te7 Max |
| Acacia Pharma INC | $112.41 | 2021 | |
| Heron Therapeutics, INC. | $18.08 | 2021 | |
| Spr Therapeutics, INC | $12.19 | 2021 | |
| Mallinckrodt Enterprises LLC | $11.16 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Gadsden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.